An applied-AI studio for the long clock.
Voice. Media. Diagnostics. Three AI companies under one studio. Two operating. One in the lab.
Ventures in market
MedNeuraX, VoxNeura
In development
MalaScan
Domains
Voice · Media · Diagnostics
Scroll to begin
↓
A studio, not a holding.
We do not pick companies. We build them. We capitalize each venture, staff it, and run it on our own balance sheet until it has its own. The model is older than AI. It is less fashionable than venture capital. It is what compounds.
Operator, not holding.
We capitalize, staff, and run the companies we build. Ventures keep their own brand, team, and roadmap. The studio absorbs long-horizon risk so they can focus on the work.
The long clock.
We measure in decades, not quarters. Quarters are tactical; decades are the frame. No one here is in a hurry, and no one here is early.
Applied only.
We build products that meet a market. If research does not reach a user, it is not the work. Papers are optional; shipping is not.
Three companies. Three markets. One operator.
Each venture runs independently, with its own domain, team, and product surface. BioNeuraX capitalizes, staffs, and operates for the long horizon.
- III
MalaScan
“From raw biological sample to medical insight.”
Computer Vision · Robotics · Point-of-Care
A diagnostic device that transforms raw biological samples into accurate medical insights. Computer vision and robotics automate the full workflow: sample handling, analysis, and reporting. Built for point-of-care settings, without a lab, technician, or network.
In DevelopmentPrivate beta
Where we have been asked to speak.
If the thesis resonates, write.
One inbox for partnerships, investors, press, and operators. Include who you are, where you are, and the problem you are closest to.
Partnerships
Clinical networks, public-health agencies, distribution partners.
Investors
Venture, development, and long-horizon capital.
Press & Talent
Media, speaking, and open roles across ventures.